| 查看: 417 | 回复: 1 | ||
| 本帖产生 1 个 翻译EPI ，点击这里进行查看 | ||
cainiaodui新虫 (小有名气)
|
[求助]
翻译求助
|
|
| Although Notch inhibitors are still preclinical, the monoclonal VEGF antibody bevacizumab is clinically available and represents a potential for combination therapy. As discussed above, some tumors are responsive to VEGF inhibition, although others are unresponsive and become resistant over time.This is most likely due to compensation by other angiogenic pathways that maintain the tumor vasculature. In patients with metastatic breast cancer, treatment with anti-VEGF therapy did not show a statistically significant increase in overall survival benefit.However, combination anti-angiogenic therapy may be useful in overcoming this resistance. |
回复此楼» 猜你喜欢
＠_＠
已经有3人回复
-
*^O^*
已经有3人回复
-
重庆理工大学副校长遇刺身亡 传涉案副教授疑因积怨行凶
已经有6人回复
-
面上项目没有好文章就没希望了吗？
已经有20人回复
-
前几天时间戳更新了
已经有10人回复
-
困死了
已经有8人回复
-
还有课题组有博士名额吗
已经有6人回复
-
博士申请
已经有3人回复
RXMCDM
版主 (文坛精英)
- 翻译EPI: 530
- 应助: 401 (硕士)
- 贵宾: 1.908
- 金币: 38947.6
- 散金: 4908
- 红花: 88
- 沙发: 4
- 帖子: 11453
- 在线: 1355.6小时
- 虫号: 2739168
- 注册: 2013-10-20
- 性别: GG
- 专业: 一般管理理论与研究方法论
- 管辖: 论文翻译
2楼2014-04-26 20:53:46